Clinical Trial

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria

Study acronym: ECLIPSE-CG
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated August 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with gastric cancer. It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Protocol Amendment History 1 change
notable Trial sites expanded: 2 -> 15 locations 2026-03-27
Trial Details
NCT Number NCT07481110
Lead Sponsor Société Algérienne de Formation et Recherche en Oncologie
Collaborators: Bristol-Myers Squibb, ES Clinical Research
Conditions Gastric Cancer, Gastric (Stomach) Cancer, Gastric Cancer (Diagnosis)
Enrollment 1,000 participants
Start Date 2025-08-05
Primary Completion 2026-08-05 (estimated)
Study Completion 2026-08-05 (estimated)
Updated on ClinicalTrials.gov 2026-03-27